15 May 2014

BioLineRx to Report First Quarter 2014 Results on May 20, 2014

Customize font size:
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it will release its unaudited financial results for the quarter ended March 31, 2014 on Tuesday, May 20, 2014, before the U.S. markets open. 
The Company will host a conference call on Tuesday, May 20 at 10:00 a.m. EDT featuring remarks by Kinneret Savitsky, Ph.D., Chief Executive Officer of BioLineRx, and Philip Serlin, Chief Financial and Operating Officer of BioLineRx. A presentation will be provided on BioLineRx’s website, to accompany management’s remarks on the conference call. The conference call will be available via webcast and can be accessed through the Investor Relations section of BioLineRx’s website, www.biolinerx.com. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast. To dial into the conference call, please dial 1-888-860-9642 from the U.S. or +972-3-918-0691 internationally. 
A replay of the conference call will be available approximately two hours after completion of the live conference call at www.biolinerx.com. A dial-in replay of the call will be available until May 23, 2014; please dial 1-888-276-1485 from the U.S. or +972-3-9255945 internationally.